Table 2.
Primary outcomes.
| Sham (n = 15) | 1×/week (n = 13) | 3×/week (n = 14) | Repeated measures (P) | Effect size (95% CI) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Time | Group × time | S versus 1× | S versus 3× | 1× versus 3× | |
| ALP (nmol/L) | 13.35 (8.3–19.7) |
13.20 (7.9–19.1) |
14.85 (8.2–33.0) |
13.60 (9.40–32.00) |
14.01 (7.01–28.00) |
13.30 (7.2–24.0) |
.08 | .27 | 0.13 (−0.61 to 0.88) |
−0.19 (−0.92 to 0.54) |
−0.25 (−1.01 to 0.51) |
| NTx/ creatinine (nm/mm Cr) |
42 (13.0–55.0) |
41 (18.0–73.0) |
38 (21.0–147.0) |
42 (22.0–102.0) |
42 (24.0– 74.0) |
36.5 (8.0–49.0) |
.21 | .03* | −0.26 (−1.00 to 0.49) |
−0.96 (−1.73 to −0.19) |
−0.28 (−1.04 to 0.48) |
All data presented as median (range).
*Indicates a significant difference between the three groups (P ≤ .05).
P values are calculated using repeated measures ANOVA to identify significance of any changes over time or group × time interactions.